Showing results (1731-1740 of 1,797) with videos related to
Sort By:
Pageof 180
Biomaterials|March 16, 2015
Stimulation of angiogenesis and survival of endothelial cells by human monoclonal Tie2 receptor antibodyByungtae Hwang, Sang-Hyun Lee, Jang-Seong Kim, et al.Gut Microbes|November 24, 2025
Cross-species engraftment biases and metabolic divergence in gnotobiotic mice humanized with ulcerative colitis microbiotaMartina A Guggeis, Nadia Andrea Andreani, Víctor A López-Agudelo, et al.Histopathology|August 29, 2025
Determinants of oncologic outcomes in high-grade organ-confined prostate cancer after prostatectomyReem Youssef, Omer Am Saeed, Ezra Baraban, et al.Blood Cancer Discovery|November 15, 2021
Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic MalignanciesDavid J Chung, Gunjan L Shah, Sean M Devlin, et al.Blood Advances|October 25, 2023
CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myelomaRoss S Firestone, Devin McAvoy, Tala Shekarkhand, et al.Gene Therapy|May 21, 2010
Branched oligomerization of cell-permeable peptides markedly enhances the transduction efficiency of adenovirus into mesenchymal stem cellsS-H Park, J Doh, S I Park, et al.Frontiers in Immunology|November 29, 2023
The gut microbiome in bullous pemphigoid: implications of the gut-skin axis for disease susceptibilityXiaolin Liu, Nina van Beek, Aleksa Cepic, et al.The Lancet. Haematology|May 28, 2021
Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trialBenjamin Diamond, Neha Korde, Alexander M Lesokhin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2024
Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated AnalysisEric M Jurgens, Ross S Firestone, Jagrutiben Chaudhari, et al.Research Square|June 17, 2024
Colesevelam for Lenalidomide Associated Diarrhea in Patients with Multiple MyelomaMalin Hultcrantz, Hani Hassoun, Neha Korde, et al.Pageof 180